Company profile: ProtoKinetix
1.1 - Company Overview
Company description
- Provider of biotechnology solutions for medical researchers to enhance cell survival and health in vitro and in vivo via AAGP®, a patented anti-aging glycopeptide. Offerings include cell and organ storage, regenerative medicine (e.g., Type 1 diabetes, macular degeneration), transplant support, biomanufacturing support, and clinical research applications in ophthalmology and dermatology.
Products and services
- AAGP®: A patented anti-aging glycopeptide that enhances cell survival and functionality in vitro and in vivo across ophthalmology, dermatology, transplant support, and biomanufacturing
- Regenerative Medicine: AAGP®-enabled treatments protect and enhance survival of transplanted cells for Type 1 diabetes and macular degeneration within regenerative medicine programs
- Cell and Organ Storage: AAGP®-integrated preservation systems improve storage of cells and organs, potentially enhancing transplant outcomes and supporting medical research applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ProtoKinetix
Helapet
HQ: United Kingdom
Website
- Description: Provider of medical and cleanroom consumables as a manufacturer and distributor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helapet company profile →
ThermoGenesis
HQ: United States
Website
- Description: Provider of automated technologies for cell-based therapeutics and bioprocessing, including BioArchive for computer-controlled preservation of cells with traceability; X-LAB for rapid, closed-system mononuclear cell isolation; PXP-1000 for automated cord blood stem cell processing; 3D Bag Set for buffy coat transfer with sterile cryoprotectant addition for long-term storage; and cleanroom and wet lab facilities for life science startups.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ThermoGenesis company profile →
Cytena
HQ: Germany
Website
- Description: Provider of single-cell printing and isolation technologies for cell research and professional diagnostics, offering the cy-Clone device to separate single cells for biologics development and genetic analysis in cancer and stem cell research, and instruments including UP.SIGHT, C.SIGHT 2.0, B.SIGHT, CELLCYTE X, C.WASH PLUS, and the C.LIVE Caspase-3 Green NucView assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytena company profile →
LI-COR
HQ: United States
Website
- Description: Provider of highly engineered instrumentation systems, analysis software, and reagents for environmental and plant research, gas analysis, agriculture, drug discovery, protein research, and small animal imaging; used in more than 100 countries and on the International Space Station.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LI-COR company profile →
SeraCare Life Sciences
HQ: United States
Website
- Description: Provider of products and services facilitating R&D and production of human and animal diagnostics and therapeutics, including diagnostic controls, plasma-derived reagents, molecular biomarkers, biobanking, clinical genomics NGS reference standards, infectious disease assay tools, immunoassay reagents, OEM biological materials for assay developers, NGS cancer profiling controls, and purified human blood fractions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeraCare Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ProtoKinetix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ProtoKinetix
2.2 - Growth funds investing in similar companies to ProtoKinetix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ProtoKinetix
4.2 - Public trading comparable groups for ProtoKinetix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →